Evidence map›Paper›PMID 33888633›Full record

ArticleScience (New York, N.Y.)2021

Partial immunity and SARS-CoV-2 mutations-Response.

Chadi M Saad-Roy, Sinead E Morris, C Jessica E Metcalf, Michael J Mina, Rachel E Baker, Jeremy Farrar, Edward C Holmes, Oliver G Pybus, Andrea L Graham, Simon A Levin and 2 more

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Science (New York, N.Y.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Chadi M Saad-RoyLewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ 08540, USA. csaadroy@princeton.edu grenfell@princeton.edu caroline.wagner@mcgill.ca.
Sinead E MorrisDepartment of Pathology and Cell Biology, Columbia University Medical Center, New York, NY 10032, USA.
C Jessica E MetcalfDepartment of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ 08544, USA.
Michael J MinaDepartments of Epidemiology and Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
Rachel E BakerDepartment of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ 08544, USA.
Jeremy FarrarThe Wellcome Trust, London NW1 2BE, UK.
Edward C HolmesMarie Bashir Institute for Infectious Diseases and Biosecurity, School of Life and Environmental Sciences, and School of Medical Sciences, The University of Sydney, Sydney, NSW 2006, Australia.
Oliver G PybusDepartment of Zoology, University of Oxford, Oxford OX1 3SZ, UK.
Andrea L GrahamDepartment of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ 08544, USA.
Simon A LevinDepartment of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ 08544, USA.
Bryan T GrenfellDepartment of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ 08544, USA. csaadroy@princeton.edu grenfell@princeton.edu caroline.wagner@mcgill.ca.
Caroline E WagnerDepartment of Bioengineering, McGill University, Montreal, QC H3A 0C3, Canada. csaadroy@princeton.edu grenfell@princeton.edu caroline.wagner@mcgill.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19SARS-CoV-2Antibodies, ViralHumansMutationSpike Glycoprotein, CoronavirusAntibodies, ViralSpike Glycoprotein, Coronavirus

Identifiers

PMID33888633

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.